Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Spring;12(2-3):e134-46.

Best of the AUA Annual Meeting: Highlights From the 2010 American Urological Association Meeting, May 29-June 3, 2010, San Francisco, CA

J Curtis Nickel  1 , Akira Furuta, Michael B Chancellor, Claus G Roehrborn, Dean G Assimos, Ellen Shapiro, Michael K Brawer
Affiliations

Best of the AUA Annual Meeting: Highlights From the 2010 American Urological Association Meeting, May 29-June 3, 2010, San Francisco, CA

J Curtis Nickel et al. Rev Urol. 2010 Spring.
No abstract available

Keywords: Autologous muscle-derived cells; Botulinum toxin; Escherichia coli; Nocturia; PRX3.02; Prostate-specific antigen; Prostatic urethral lift; Shock wave lithotripsy; Synthetic mesh sling; Transrectal ultrasound prostate; Uropsis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The durable effect of desmopressin orally disintegrating tablet.
Figure 2
Figure 2
Combination 4-year therapy reduces incidence of acute urinary retention (AUR) or benign prostatic hyperplasia (BPH)-related surgery. RRR, risk reduction range.
Figure 3
Figure 3
Reduced incidence of acute urinary retention (AUR) or benign prostatic hyperplasia (BPH)-related surgery with dutasteride over a 4-year study. IPSS, International Prostate Symptom Score; PV, prostate volume; RRR, risk reduction range.
Figure 4
Figure 4
Reduction in Chronic Prostatitis Symptom Index score in prostatitis-like pain subgroup.
Figure 5
Figure 5
Efficacy results: mean change in International Prostate Symptom Score (IPSS) (PRX3.02 vs placebo). ANCOVA, analysis of covariance.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Nam R, Klotz L, Loblaw A, et al. Rising hospital admission rates for urologic complications after transrectal ultrasound-guided prostate biopsy [abstract 2097] J Urol. 2010;183(suppl):e815. - PubMed
    1. Loeb S, Carter HB, Berndt S, et al. How safe is prostate biopsy? Rate of complications requiring hospitalization following prostate biopsy in SEER-Medicare [abstract 2096] J Urol. 2010;183(suppl):e815.
    1. Casey JT, Kim RJ, Alpha HH, et al. Hospitalization for fever after transrectal ultrasound-guided prostate needle biopsy [abstract 609] J Urol. 2010;183(suppl):e240.
    1. Cermak A, Mareckova N, Pacik D. Infectious complications of prostate biopsy: the changes in antibiotics resistance patterns-the review of a 5-year period [abstract 2101] J Urol. 2010;183(suppl):e817.
    1. Jung S, Park JB, Hwang EC, et al. Clinical aspect of post TRUS biopsy infection caused by quinolone-resistant bacteria [abstract 808] J Urol. 2010;183(suppl):e315–e316.

LinkOut - more resources